A Search for Novel Antidiabetic Agents Using Ligand-Based Drug Design and Molecular Docking Studies Employing Human Intestinal Maltase-Glucoamylase as Model Enzyme
Journal: Advanced Journal of Chemistry-Section A (Vol.6, No. 2)Publication Date: 2023-04-01
Authors : Khalifa Sunusi Aminu; Adamu Uzairu; Stephen Eyije Abechi; Gideon Shallangwa Adamu; Abdullahi Bello Umar;
Page : 155-171
Keywords : Quantitative structure activity relationship; Antidiabetic agents; Molecular docking; Molegro virtual docker; Density functional theory;
Abstract
This study employed quantitative structure-activity relationship (QSAR) to predict the inhibitory activities of N-(alkyl/aryl)-2-chloro-4-nitro-5-[(4-nitrophenyl) sulfamoyl] benzamide derivatives as potent inhibitors of C-terminal human intestinal maltase-glucoamylase (MGAM-C). Density Functional Theory with B3LYP/6-31G* as the basis set was used to optimize the chemical structures of the derivatives. Genetic function approximation generated three models, with model one having validation keys of R2int= 0.989, R2adj = 0.984, Q2cv = 0.974, and LOF = 0.0056 being selected as the best due to it highest external validation parameter of R2ext = 0.722. The ligand-based approach designed four compounds with higher activities than the lead compound. The binding interactions of the designed compounds within the active site of (MGAM-C) revealed interesting MolDock scores. This research concluded that the designed compounds from the derivatives could serve as potent inhibitors of MGAM-C, offering valuable insight into developing novel medications to treat diabetes mellitus.
Other Latest Articles
- Theoretical Investigations on Thiadiazole Derivatives as Corrosion Inhibitors on Mild Steel
- Inhibitory Activity of Natural Flavonoids against Protein Aggregation in Alzheimer's disease: A Computational Simulation Study
- Effect of Nanoparticles on the Degradation, Ageing and other Properties of Ester-based Nanofluids
- Theoretical Investigation and Design of Novel Anti-proliferative Agents against Hepatocellular Carcinoma from Benzimidazole-Chalcone derivatives
- INNOVATIVE MODEL TO AUGMENT SMALL DATASETS FOR CLASSIFICATION
Last modified: 2023-05-11 20:42:34